A 14-year Swedish study showed that a prostate-specific antigen blood test reduced mortality from prostate cancer by nearly 50%. Researchers found that 44 of 10,000 men who were screened for prostate cancer every two years died of the disease compared with 78 of 10,000 who hadn't undergone screening.

Full Story:

Related Summaries